| (11) | Number of the document | 4589 |
| (21) | Number of the application | a 2014 0035 |
| (22) | Filing date of the application | 2012.09.14 |
| | Date of filing the request for examination | (de fond) 04.10.2016 |
| (71) | Name(s) of applicant(s), code of the country | GILEAD PHARMASSET LLC, US; |
| (72) | Name(s) of inventor(s), code of the country | RAY Adrian S., US; WATKINS William J., US; LINK John O., US; OLDACH David W., US; DELANEY IV William E., US; |
| (73) | Name(s) of owner(s), code of the country | GILEAD PHARMASSET LLC, US; |
| (54) | Title of the invention | Pharmaceutical composition comprising sofosbuvir and uses thereof for treating hepatitis C virus |
| (13) | Kind-of-document code | |
| (51) | International Patent Classification | A61K 31/513 (2006.01); A61K 31/4184 (2006.01); A61K 31/381 (2006.01); A61P 31/14 (2006.01); |
| (19) | Country | US |
| (41) | Date of publication of the application | 2014.08.31 |
| (45) | Date of publication of patent granting decision: | 2018.08.31 |
| (47) | Date of issuance of patent | 2019.03.31 |
| (30) | Priority | 61/535885, 2011.09.16, US; 61/561753, 2011.11.18, US |
| (74) | Patent attorney | MARGINE Ion, Str. Lomonosov nr. 43, ap. 23, MD-2009, Chişinău, Republica Moldova |
| | Substantive examiner(s) | LUPAŞCU Lucian, STAFI Radu |
| (85) | Date of introducing the national procedure | 2014.04.08 |
| (86) | International application | PCT/US2012/055621, 2012.09.14 |
| (87) | International publication | WO 2013/040492 A2, 2013.03.21 |
| | Payment for maintenance up to the date | 2019.09.14 |
| | Date of patent termination | 2019.09.14 |
| | Date of publication of the termination of patent, with the right of restoration | 2020.04.30 |
| | Date of publication of the termination of patent, without the right of restoration | 2021.04.30 |